We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Improving access to insulin.
- Abstract
The article focuses on the efforts of the public health community to reduce insulin prices to improve access to diabetes treatments and technologies in 2021. Topics discussed include the inclusion of research and development spending in insulin prices according to producers Eli Lilly, Novo Nordisk and Sanofi, effect of lack of transparency on insulin production expenditures on establishing fair pricing, and the preparations for Global Diabetes Compact collaborative agreement.
- Subjects
UNITED States; INSULIN therapy; HEALTH services accessibility; TYPE 1 diabetes; MEDICAL care costs; INSULIN; TYPE 2 diabetes; QUALITY assurance
- Publication
Bulletin of the World Health Organization, 2021, Vol 99, Issue 4, p246
- ISSN
0042-9686
- Publication type
Article
- DOI
10.2471/BLT.21.020421